Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

Objectives: The aim of this study was to review the requirements for the reimbursement of biosimilars and to compare the reimbursement status, market share, and reimbursement costs of biosimilars in selected Central and Eastern European (CEE) countries. Methods: A questionnaire-based survey was cond...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Kawalec, Paweł, Stawowczyk, Ewa, Tesar, Tomas, Skoupa, Jana, Turcu-Stiolica, Adina, Dimitrova, Maria, Petrova, Guenka I., Rugaja, Zinta, Männik, Agnes, Harsanyi, Andras, Draganic, Pero
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2017
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463127/
https://ncbi.nlm.nih.gov/pubmed/28642700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00288
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires